.jpg)
.png)
All
Lipoprotein(a) [Lp(a)] is an independent risk factor for atherosclerotic cardiovascular disease (ASCVD). Although approximately 20% of the population has elevated Lp(a) levels (≥ 50 mg/dL or 125 nmol/L), there are currently no approved targeted medical treatments available. Lp(a) has a unique... more
Discuss this article at www.lipid.org/lipidspin Diabetes mellitus (DM) is a leading cause of cardiovascular disease (CVD) and its associated morbidity and mortality.(1) DM confers the highest lifetime risk of any individual risk factor for developing cardiovascular disease. Although morbidity... more
To honor the exceptional professionals in our ranks, the NLA has established several types of recognition. We are currently seeking nominations for the following awards, to be presented at the NLA Scientific Sessions, May 18-21, 2017, at the Philadelphia Marriott Downtown: NLA Honorary... more
h3{ margin-bottom:10px; } Advocacy Committee The Advocacy Committee is focused on (1) supporting current relationships with like-minded organizations, (2) identifying opportunities for new relationships with strategic partners to improve the visibility... more
The 2014 Impact Factors were recently released and the Journal of Clinical Lipidology (JCL) saw another increase — from 3.587 (2013) to 3.904 (2014). The Journal is now ranked 44th out of 254 journals in its category (pharmacology and pharmacy). The Thomson-... more
Be sure to read the latest JCL Roundtable featuring Lauren Williams, RDN, Lynne T. Braun, PhD, CNP, FNLA, Joseph J. Saseen, PharmD, FNLA, and John R. Guyton, MD, FNLA discussing the importance of the lipidology team. Abstract Clinical lipidology practice works best when implemented by a... more
Introduction Despite significant advances in detection and treatment, cardiovascular disease (CVD) is the leading cause of death and disability worldwide.(1,2) The 3-hydroxymethylglutaryl coenzyme A (HMGCoA) reductase inhibitors (aka statins) ushered in a new era for prevention of cardiovascular... more
When Tara Dall, MD, began her medical career, it was in 2001, after she graduated from medical school and completed her residency at the University of Wisconsin at Madison. She started as a family practice physician with no specialization in lipidology. That changed quickly, however, when she saw... more
It has been my distinct pleasure to serve as President of the National Lipid Association (NLA) during the 2013/2014 term. I am thankful to have been a part of the leadership in an organization with so many dedicated colleagues. I was blessed to serve with a wonderful Executive Committee and... more